Activity of fludarabine in previously treated Waldenstrom's macroglobulinemia: A report of 71 cases

Journal of Clinical Oncology

Volumn 16, Issue 6, 1998, Pages 2060-2064

  Leblond, Véronique ^a   Ben Othman, Tarek ^a   Deconinck, Eric ^a   Taksin, Anne Laure ^a   Harousseau, Jean Luc ^a   Delgado, Maria Angeles ^a   Delmer, Alain ^a   Maloisel, Frédéric ^a   Mariette, Xavier ^a   Morel, Pierre ^a   Clauvel, Jean Pierre ^a   Duboisset, Pascal ^a   Entezam, Saharad ^a   Hermine, Olivier ^a   Merlet, Maryse ^a   Yakoub Agha, Ibrahim ^a   Guibon, Odile ^a   Caspard, Hervé ^a   Fort, Nicole ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE; HEMOGLOBIN; IMMUNOGLOBULIN M; NUCLEOSIDE ANALOG;

ADULT; AGED; ARTICLE; DRUG ACTIVITY; DRUG EFFICACY; HEMOGLOBIN DETERMINATION; HUMAN; HYPERVISCOSITY SYNDROME; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT FAILURE; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0031778016     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.6.2060     Document Type: Article

References (22)

1. Waldenström JG: Incipient myelomatosis or "essential" hyperglobulinemia with fibrinogenopenia - A new syndrome? Acta Med Scand 117:216-222, 1944
2. Dimopoulos MA, Alexanian R: Waldenstrom's macroglobulinemia. Blood 83:1452-1459, 1994
3. MacKenzie MR, Fudenberg HH: Macroglobulinemia: An analysis of forty patients. Blood 39:874-889, 1972
4. Brouet JC, Clauvel JP, Seligmann M: Evolution et pronostic de la maladie de Waldenström. Etude de 150 observations. Act Hématol (Paris) 9:38-47, 1975
5. Petrucci MT, Avvisati G, Tribalto M, et al: Waldenstrom's macroglobulinemia: Results of a combined oral treatment in 34 newly diagnosed patients. J Intern Med 226:443-447, 1989
6. Case DC, Errin TJ, Boyd MA, et al: Waldenstrom's macroglobulinemia: Long term results with the M2-protocol. Cancer Invest 9:1-7, 1991
7. Rotoli B, De Renzo A, Frigeri F, et al: A phase II trial on alpha-interferon (α IFN) effect in patients with monoclonal IgM gammopathy. Leuk Lymphoma 13:463-469, 1994
8. Kantarjian HM, Alexanian R, Koller CA, et al: Fludarabine therapy in macroglobulinemic lymphoma. Blood 75:1928-1931, 1990
9. Dimopoulos MA, Kantarjian H, Estey E, et al: Treatment of Waldenstrom's macroglobulinemia with 2-chlorodeoxyadenosine. Ann Intern Med 118:195-198, 1993
10. Delannoy A, Ferrant A, Martial P, et al: 2-chlorodeoxyadenosine therapy in Waldenstrom's macroglobulinemia. Nouv Rev Hematol 36:317-320, 1994
11. Dimopoulos MA, O'Brien S, Kantarjian H, et al: Fludarabine therapy in Waldenstrom's macroglobulinemia. Am J Med 95:49-52, 1993
12. Dimopoulos MA, Kantarjian H, Weber D, et al: Primary treatment of Waldenstrom's macroglobulinemia with 2-chlorodeoxyadenosine. J Clin Oncol 12:2694-2698, 1994
13. Zinzani PL, Gherlinzoni F, Bendandi M, et al: Fludarabine treatment in resistant of Waldenstrom's macroglobulinemia. Eur J Hematol 54:120-123, 1995
14. Dimopoulos MA, O'Brien S, Estey EE, et al: Treatment of Waldenstrom's macroglobulinemia with the nucleoside analogues fludarabine or 2-chlorodeoxyadenosine. Leuk Lymphoma 11:105-108, 1993
15. Mc Laughin P, Alexanian R: Myeloma protein kinetics following chemotherapy. Blood 60:851-854, 1982
16. Kaplan E, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
17. Facon T, Bouillard M, Duhamel A, et al: Prognostic factors in Waldenstrom's macroglobulinemia: A report of 167 cases. J Clin Oncol 11:1553-1558, 1993
18. Gobbi PG, Bettini R, Montecucco C, et al: Study of prognosis in Waldenstrom's macroglobulinemia: A proposal for a simple binary classification with clinical and investigational utility. Blood 83:2939-2945, 1994
19. Quesada JR, Alexanian R, Kurzrock R, et al: Recombinant interferon gamma in hairy cell leukemia, multiple myeloma and Waldenstrom's macroglobulinemia. Am J Hematol 29:1 -4, 1988
20. Tallman MS, Hakimian D: Purine nucleoside analogs: Emerging roles in indolent lymphoproliferative disorders. Blood 86:2463-2474, 1995
21. Bergmann L, Fenchel K, Jahn B, et al: Immunosuppressive effect and clinical response of fludarabine in refractory chronic lymphocytic leukemia. Ann Oncol 4:371-375, 1993
22. Rabinowe SN, Soiffier RJ, Gribben JG, et al: Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 82:1366-1376, 1993